DR Profile
Lonza Group
Business Summary
Lonza Group is engaged in the supply of chemicals, solutions and services to the pharmaceutical, healthcare and life science industries. The Company's operations are organized along three segments: Custom Manufacturing; Life Science Ingredients; and Bioscience. The Company's Custom Manufacturing segment produces ingredients that are used in several drugs, treating patients in areas such as cardiovascular diseases, cancer, neurological and infectious diseases. The Company's Life Science Ingredients segment provides products used in nutrition, microbial control as well as in selected industrial markets. The Company's Bioscience segment produces tools use to discover, develop, make and test therapeutics.
Data provided by Mergent, Inc.Recent Company News
Powered by Interactive Data Managed Solutions
Recent Dividends & Distributions
| US Record Date | US Payable Date | Net DR Amount |
|---|---|---|
| Apr 15, 2013 | May 01, 2013 | 0.2076 |
| Apr 11, 2012 | Apr 27, 2012 | 0.2111 |
| Apr 18, 2011 | May 04, 2011 | 0.2159 |
| DR Symbol | LZAGY |
| CUSIP | 54338V101 |
| DR Exchange | OTC |
| DR ISIN | US54338V1017 |
| Ratio | 10:1 |
| Depositary | BK, CIT, DB, JPMC (Unsponsored) |
| First Filer | BK |
| Effective Date | Oct 10, 2008 |
| Underlying ISIN | CH0013841017 |
| Underlying SEDOL | 7333378 |
| Country | Switzerland |
| Industry | Pharma. & Biotech. |
Monthly DR Trading Summary
| Month |
Month End DR Close Price |
DR Trading Volume |
Avg Day DR Trading Volume |
|---|---|---|---|
 Apr. 13 |
6.93 | 1,118,996 | 50,863 |
| Mar. 13 |
6.48 | 1,277,612 | 63,881 |
| Feb. 13 |
6.18 | 1,804,468 | 94,972 |
Important Notice to Investors of Unsponsored DRs:
From time to time BNY Mellon may pay a rebate to brokers that deposit shares with BNY Mellon for the issuance of unsponsored depositary receipts. BNY Mellon assumes no obligation or responsibility, and expressly disclaims any liability arising out of, or relating to, such rebates, including without limitation whether the rebate or any portion of it is passed on to the beneficial holders by the brokers.
This DR is a Constituent of the following BNY Mellon DR Indices:
|
Related linksCustodians / BIC |
Helpful Links |
This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE
Please refer to "Terms Of Use".
DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE
